AOD9604 and Energy Balance Research In obese ob/ob and lean C57BL/6J mice treated for 14 days via mini-osmotic pumps, AOD9604 significantly reduced body weight gain in obese mice, associated with increased in vivo fat oxidation and increased plasma glycerol levels as an index of enhanced lipolysis without the hyperglycaemia or reduced insulin secretion associated with intact hGH treatment
The most reported side effects are self-limited gastrointestinal symptoms, including nausea, vomiting, and diarrhea, often associated with the initiation of treatment and increases in dosage [20]
Product listings are maintained with clear naming, available records, and specification details for procurement review
This makes it easier to speak with a provider, review your goals, and discuss treatment options without unnecessary travel
In addition to platform design, analytical characterization has become increasingly important for translational development
Capsaicin (topical route) - Side effects & dosage - Mayo Clinic Konstantinou K, Dunn KM